The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy
Abstract
Atrial and brain natriuretic peptides (ANP and BNP) are produced by the heart, and their plasma concentrations are increased in human chronic congestive heart failure. Although separate studies have suggested that circulating levels of the biologically active C-terminal ANP, the biologically inactive N-terminal ANP, and BNP may have diagnostic utility in the detection of left ventricular systolic dysfunction or left ventricular hypertrophy, no studies have directly assessed the relative value of these peptides prospectively. We therefore designed this study to compare the relative ability of the different natriuretic peptides to detect abnormal left ventricular systolic and diastolic function and left ventricular hypertrophy. Using a prospective study design, we investigated 94 patients referred for cardiac catheterization and 15 age-matched normal subjects. The diagnostic abilities of elevated plasma C-terminal ANP, N-terminal ANP-(1-30), and BNP concentrations to identify systolic dysfunction (ejection fraction <45%), diastolic dysfunction (time constant of left ventricular relaxation >55 milliseconds, left ventricular end-diastolic pressure >18 mm Hg), and left ventricular hypertrophy (left ventricular mass index >120 g/m 2 ) were objectively compared by receiver operating characteristic analysis. The areas under the receiver operating characteristic curve of BNP for detecting each of these abnormalities ranged from 0.715 to 0.908 and were significantly greater than those of C-terminal ANP or N-terminal ANP-(1-30). The sensitivity and specificity of an elevated plasma BNP, which we defined as greater than the mean+3 SD of the 15 age-matched normal subjects, were 0.83 and 0.77, respectively, for detecting ejection fraction less than 45%, 0.85 and 0.70 for detecting the time constant of left ventricular relaxation greater than 55 milliseconds, 0.63 and 0.76 for detecting left ventricular end-diastolic pressure greater than 18 mm Hg, and 0.81 and 0.85 for detecting left ventricular mass index greater than 120 g/m 2 . The use of BNP and one other peptide increased sensitivity (0.90 to 0.96), albeit with lower specificity (0.56 to 0.71). An elevated plasma BNP was a more powerful marker of left ventricular systolic dysfunction, left ventricular diastolic dysfunction, and left ventricular hypertrophy than C-terminal ANP or N-terminal ANP-(1-30) in this population of patients with suspected cardiac disease. Measurement of BNP alone or in combination with C-terminal ANP or N-terminal ANP-(1-30) has potential utility for the detection of altered left ventricular structure and function in a patient population at risk for cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,229
Appleton, C. P., Hatle, L. K., & Popp, R. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90416-0 · Cited by 1,568
Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,388
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., & Yasue, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115146 · Cited by 1,354
Self-citationYasue, H., Yoshimura, M., Sumida, H., Kikuta, K., Kugiyama, K., Jougasaki, M., Ogawa, H., Okumura, K., Mukoyama, M., & Nakao, K. (1994) · Circulation · doi:10.1161/01.cir.90.1.195 · Cited by 1,333
Self-citationHemodynamic determinants of the time-course of fall in canine left ventricular pressure.
Weiss, J. L., Frederiksen, J. W., & Weisfeldt, M. L. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108522 · Cited by 1,077
Diverse biological actions of atrial natriuretic peptide
Brenner, B. M., Ballermann, B. J., Gunning, M. E., & Zeidel, M. L. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.3.665 · Cited by 906
Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human
Burnett, J. C., Kao, P. C., Hu, D. C., Heser, D. W., Heublein, D., Granger, J. P., Opgenorth, T. J., & Reeder, G. S. (1986) · Science · doi:10.1126/science.2935937 · Cited by 891
Self-citationKannel, W. B., & Belanger, A. J. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90225-7 · Cited by 797
Cited by
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Self-citationPlasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
Plasma brain natriuretic peptide concentration: impact of age and gender
Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J., Mahoney, D. W., Bailey, K. R., & Burnett, J. C. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02059-4 · Cited by 1,138
Self-citationB-type natriuretic peptide in cardiovascular disease
de Lemos, J. A., McGuire, D. K., & Drazner, M. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13976-1 · Cited by 1,067
Tsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ono, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 704
Self-citationRichards, A. M., Nicholls, M. G., Yandle, T. G., Frampton, C., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Cardiac fibrosis in mice lacking brain natriuretic peptide
Tamura, N., Ogawa, Y., Chusho, H., Nakamura, K., Nakao, K., Suda, M., Kasahara, M., Hashimoto, R., Katsuura, G., Mukoyama, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070371497 · Cited by 620
Self-citationIwanaga, Y., Nishi, I., Furuichi, S., Noguchi, T., Sase, K., Kihara, Y., Goto, Y., & Nonogi, H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.030 · Cited by 533
Mant, J., Doust, J., Roalfe, A., Barton, P., Cowie, M., Glasziou, P., Mant, D., McManus, R., Holder, R., Deeks, J., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13320 · Cited by 498
Vasan, R. S., Benjamin, E. J., Larson, M. G., Leip, E. P., Wang, T. J., Wilson, P. W. F., & Levy, D. (2002) · JAMA · doi:10.1001/jama.288.10.1252 · Cited by 493
Impact of age and sex on plasma natriuretic peptide levels in healthy adults
Wang, T. J., Larson, M. G., Levy, D., Leip, E. P., Benjamin, E. J., Wilson, P. W. F., Sutherland, P., Omland, T., & Vasan, R. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02464-5 · Cited by 471
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
Richards, A. M., Nicholls, M. G., Espiner, E. A., Lainchbury, J. G., Troughton, R. W., Elliott, J., Frampton, C., Turner, J., Crozier, I. G., & Yandle, T. G. (2003) · Circulation · doi:10.1161/01.cir.0000070953.76250.b9 · Cited by 436
Cellular mechanisms of cardiac hypertrophy
Sugden, P. H., & Clerk, A. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050275 · Cited by 404
Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure
Koglin, J., Pehlivanli, S., Schwaiblmair, M., Vogeser, M., Cremer, P., & vonScheidt, W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01672-2 · Cited by 404
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin
Richards, A. M., Doughty, R., Nicholls, M. G., MacMahon, S., Sharpe, N., Murphy, J., Espiner, E. A., Frampton, C., & Yandle, T. G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01269-4 · Cited by 389
Candidate‐based proteomics in the search for biomarkers of cardiovascular disease
Anderson, L. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.080473 · Cited by 378
Raymond, I., Groenning, B. A., Hildebrandt, P. R., Nilsson, J. C., Baumann, M., Trawinski, J., & Pedersen, F. (2003) · Heart · doi:10.1136/heart.89.7.745 · Cited by 351
Mills, R. M., LeJemtel, T. H., Horton, D. P., Liang, C.-S., Lang, R., Silver, M. A., Lui, C., & Chatterjee, K. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00184-9 · Cited by 324
A Systematic Review of the Diagnostic Accuracy of Natriuretic Peptides for Heart Failure
Doust, J. A., Glasziou, P. P., Pietrzak, E., & Dobson, A. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.18.1978 · Cited by 323
ZOCCALI, C., MALLAMACI, F., BENEDETTO, F. A., TRIPEPI, G., PARLONGO, S., CATALIOTTI, A., CUTRUPI, S., GIACONE, G., BELLANUOVA, I., COTTINI, E., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271508 · Cited by 320
Yamamoto, K., Nishimura, R. A., Chaliki, H. P., Appleton, C. P., Holmes, D. R., & Redfield, M. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00390-2 · Cited by 274
Self-citationHawkridge, A. M., Heublein, D. M., Bergen, H. R., Cataliotti, A., Burnett, J. C., & Muddiman, D. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508782102 · Cited by 266
Self-citationDifferential atrial and ventricular expression of myocardial BNP during evolution of heart failure
Luchner, A., Stevens, T. L., Borgeson, D. D., Redfield, M., Wei, C.-M., Porter, J. G., & Burnett, J. C. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.5.h1684 · Cited by 256
Self-citationCardiac Hormones as Diagnostic Tools in Heart Failure
Ruskoaho, H. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0006 · Cited by 252
The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening
Wang, T. J., Levy, D., Benjamin, E. J., & Vasan, R. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00012 · Cited by 229
Lambadiari, V., Pavlidis, G., Kousathana, F., Varoudi, M., Vlastos, D., Maratou, E., Georgiou, D., Andreadou, I., Parissis, J., Triantafyllidi, H., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0646-z · Cited by 146
Natriuretic peptides as markers of preclinical cardiac disease in obesity
Grandi, A. M., Laurita, E., Selva, E., Piantanida, E., Imperiale, D., Giovanella, L., Guasti, L., & Venco, A. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01348.x · Cited by 43
Abdulle, A. M., Nagelkerke, N. J. D., Adem, A., Abouchacra, S., Pathan, J. Y., Al-Rukhaimi, M., Suleiman, M. N., Mathew, M. C., Nicholls, M. G., & Obineche, E. N. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002210 · Cited by 11
Metadata
- Authors
- Yamamoto, K., Burnett, J. C., Jougasaki, M., Nishimura, R. A., Bailey, K. R., Saito, Y., Nakao, K., & Redfield, M. M.
- Venue
- Hypertension
- Published
- 1996-12
- Volume
- 28
- Issue
- 6
- Pages
- 988-994
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W1995588722
- Cited by
- 524
- References
- 35
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.